Neurotoxicity of interferon-α in melanoma therapy: Results from a randomized controlled trial

Cancer

Volumn 83, Issue 3, 1998, Pages 482-489

  Caraceni, Augusto ^a   Gangeri, Laura ^a   Martini, Cinzia ^a   Belli, Filiberto ^a   Brunelli, Cinzia ^a   Baldini, Maria ^a   Mascheroni, Luigi ^a   Lenisa, Leonardo ^a   Cascinelli, Natale ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Adjuvant immunotherapy; Interferon ; Malignant melanoma; Neurologic side effects; Quality of life

Indexed keywords

RECOMBINANT ALPHA2A INTERFERON;

ADULT; ANXIETY; ARTICLE; CANCER IMMUNOTHERAPY; CLINICAL TRIAL; CONTROLLED STUDY; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; NEUROTOXICITY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREMOR;

ADULT; ANXIETY; BRAIN; COGNITION DISORDERS; FEMALE; HUMANS; INTERFERON ALFA-2A; MALE; MELANOMA; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0032147162     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980801)83:3<482::AID-CNCR17>3.0.CO;2-S     Document Type: Article

References (31)

1. Balch CM, Soong S, Milton GW, Shaw HM, McGovern VJ, Murad TM, et al. A comparison of prognostic factors and surgical resultsin 1,786 patients with localized (stage I) melanoma treated in Alabama, USA and New South Wales, Australia. Ann Surg 1982;196:677-84.
2. Belli F, Mascheroni L, Cascinelli N. Potential role of interferons in the treatmnet of metastatic melanoma. In: Maio M, editor. Immunology of human melanoma. Bruxelles: IOS Press, 1996:217-26.
3. Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the eastern cooperative oncology group trial EST 1684. J Clin Oncol 1996;14: 7-17.
4. Spiegel RJ. The alpha interferons: clinical overview. Semin Oncol 1987;14(2(S2)):1-12.
5. Quesada JR, Hawkins M, Horning S, Alexanian R, Borden E, Merigan T, et al. Collaborative phase I-II study of recombinant DNA-produced leukocyte Interferon (clone A) in metastatic breast cancer, malignant lymphoma and multiple myeloma. Am J Med 1984;77:427-32.
6. Kirkwood JM, Ernstoff MS, Davis CA, Reiss M, Ferraresi R, Rudnick SA. Comparison of intramuscular and intravenous recombinant alpha-2 Interferon in melanoma and other cancers. Ann Intern Med 1985;103:32-6.
7. Adams F, Quesada JR, Gutterman JU. Neuropsychiatric manifestations of human leukocyte Interferon therapy in patients with cancer. JAMA 1984;252:938-41.
8. Meyers CA, Scheibel RS, Forman AD. Persistent neurotoxicity of systemically administered interferon-alpha. Neurology 1991;41:672-6.
9. Rohatiner AZS, Prior PF, Burton AC, Smith AT, Balkwill FR, Lister TA. Central nervos system toxicity of intereferon. Br J Cancer 1983;47:419-22.
10. Adams F, Fernanadez F, Mavligit G. Interferon-induced organic mental disorders associated with unsuspected preexisting neurologic abnormalities. J Neurooncol 1988; 6:355-9.
11. Merimsky O, Reider-Groswasser I, Inbar M, Chaitchik S. Interferon-related mental deterioration and behavioral changes in patients with renal cell carcinoma. Eur J Cancer 1990;26:596-600.
12. Merimsky O, Nisipeanu P, Loewenstein A, Reider-Groswasser I, Chaitchik S. Interferon-related conical blindness. Cancer Chemother Pharmacol 1992;29:329-30.
13. Hagberg H, Blomkvist E, Ponten U, Persson L, Muhr C, Eriksson B, et al. Does alpha-interferon in conjunction with radiotherapy increase the risk of complications in the central nervous system. Ann Oncol 1990;1:449-51.
14. Forman AD. Neurologic complication of cytokine therapy. Oncology 1994;8:105-10.
15. Mattson K, Niiranen A, Iivanainen M, Farkkila M, Bergstrom I, Holsti LR, et al. Neurotoxicity of interferon. Cancer Treat Rep 1983;67:958-61.
16. Meyers CA, Obbens E, Scheibel RS, Moser RP. Neurotoxicity of intraventricularly administered alpha-interferon for leptomeningeal disease. Cancer 1991;68:88-92.
17. Fahn S, Marsden CD, Calne DB. Recent developments in Parkinson's Disease. Florham Park: MacMillian Health Care Information, 1987:153-63, 293-304.
18. Overall JE, Hollister LE, Pichot P. Major psychiatric disorders. A four dimensional model. Arch Gen Psychiatry 1967; 16:146.
19. Spinier H, Tognoni G. Standardizzazione e taratura Italiana di test neuropsicologici. Ital J Neurol Sci 1987;6(S 8).
20. De Santi G, Menini R. Manuale del test AIT di R. Meili. Firenze: Organizzazioni Special, 1981.
21. Pinco. Manuale di diagnostica psicologica. Firenze: Giunti, 1967.
22. Zazzo R. Manuel pour l'examen pychologique de l'enfant, Neuchatel: Delachaux et Niestlé, 1969.
23. Spielberger CD. Manual for the state-trait anxiety inventory. Palo Alto: Consulting Psychologists Press, 1983.
24. Tamburini M, Rosso S, Gamba A, Mencaglia E, De Conno F, Ventafridda V. A therapy impact questionnaire for quality-of-life assessment in advanced cancer research. Ann Oncol 1992;3:565-70.
25. Mattews JNS, Altman DG, Campbel MJ, Royston P. Analysis of serial measurement in medical research. BMJ 1990;300: 230-5.
26. Lehman EL. Nonparametrics: statistical methods based on ranks. San Francisco: Holden-Day, 1975.
27. Bruera E, Macmillan K, Hanson J, MacDonald RN. The cognitive effects of the administration of narcotic analgesics in patients with cancer pain. Pain 1989;39:13-6.
28. Bruera E, Miller MJ, Macmillan K, Kuhen N. Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain. Pain 1992; 48:163-6.
29. Girotti F, Carella F, Grassi MP, Soliveri P, Marano R, Caraceni T. Motor and cognitive performaces of Parkinsonian patients in the on and off phases of the disease. J Neurol Neurosurg Psychiatry 1986;49:657-60.
30. Cassileth BR, Knuiman MW, Abeloff MD, Falkson G, Ezdinli EZ, Mehta CR. Anxiety levels in patients randomized to adjuvant therapy versus observation for early breast cancer. J Clin Oncol 1986;4:972-4.
31. Ventafridda V, DeConno F, Ripamonti C, Gamba A, Tamburini M. Quality of life assessment during a palliative care program. Ann Oncol 1990;1:415-20.